Catalyst
Slingshot members are tracking this event:
Presentation of Chiasma's(CHMA) 5 late-breaker abstracts from the MPOWERED Phase 3 Study of octreotide capsules in Acromegaly planned at the upcoming 2021 ENDO Meeting, March 20 - 23
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CHMA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 22, 2021
Occurred Source:
https://ir.chiasma.com/news-releases/news-release-details/chiasma-presents-long-term-safety-and-efficacy-data-open-label
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Mpowered, Acromegaly, Octreotide
